Klotz L. Sunitinib, sorafenib and other systemic noncytotoxic kidney cancer therapies can and should be administered by urologists. CUAJ [Internet]. 2012 Dec. 11 [cited 2026 May 5];1(2S). Available from: https://cuaj.ca/index.php/journal/article/view/70